Abstract
The clinical integration of prenatal genetic technologies raises a series of important medical and ethical considerations for patients, families, health care providers, health care systems, and society. It is critical to recognize, understand, and address these issues in conjunction with the continued development of new prenatal genetic screens and tests. This article discusses some of the lead ethical issues as a starting point to further understanding their ramifications on patients, families, communities, and health care providers.
Original language | English (US) |
---|---|
Pages (from-to) | 127-141 |
Number of pages | 15 |
Journal | Obstetrics and Gynecology Clinics of North America |
Volume | 45 |
Issue number | 1 |
DOIs | |
State | Published - Mar 2018 |
Keywords
- Clinical translation
- Ethical issues
- Genetic tests
- Informed consent
- Patient decision making
ASJC Scopus subject areas
- Obstetrics and Gynecology